IDS and mucopolysaccharidosis type 2: Therefore, exogenous mutant z-ids mRNAs, corresponding to known mutated human IDS, as reported in MPS II patients, did not exhibit z-IDS enzyme activity significantly higher than that of the untreated control embryos.